ArticleFrontiers in pharmacology2022

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss.

Huijiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.